BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11190875)

  • 1. [HLA and multiple sclerosis. Studies of a spanish population].
    Uría DF
    Rev Neurol; 2000 Dec 1-15; 31(11):1066-70. PubMed ID: 11190875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association.
    Fernández O; Fernández V; Martinez-Cabrera V; Mayorga C; Alonso A; León A; Arnal C; Hens M; Luque G; de Ramón E; Caballero A; Leyva L
    Tissue Antigens; 2008 May; 71(5):426-33. PubMed ID: 18312478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II alleles and multiple sclerosis in Tunisian patients.
    Messadi A; Najiba FM; Ouerhani S; Zaweli J; Louatti I; Layouni S; Nciri B; Bouaicha G; Kouki W; Yedeas M; Raies A; Mrissa R; Gritli N
    Clin Neurol Neurosurg; 2010 Dec; 112(10):849-52. PubMed ID: 20691532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
    Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
    Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and HLA class II susceptibility and resistance genes.
    Haegert DG; Michaud M; Schwab C; Francis GS
    J Neurosci Res; 1990 May; 26(1):66-73. PubMed ID: 1972763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami.
    Harbo HF; Utsi E; Lorentzen AR; Kampman MT; Celius EG; Myhr KM; Lie BA; Mellgren SI; Thorsby E
    Tissue Antigens; 2007 Apr; 69(4):299-304. PubMed ID: 17389012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis in G: genes and geography.
    Tienari P; Bonetti A; Pihlaja H; Saastamoinen KP; Rantamäki T
    Clin Neurol Neurosurg; 2006 Mar; 108(3):223-6. PubMed ID: 16388895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel.
    Benedek G; Paperna T; Avidan N; Lejbkowicz I; Oksenberg JR; Wang J; Brautbar C; Israel S; Miller A;
    Genes Immun; 2010 Jul; 11(5):423-31. PubMed ID: 20463743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenetics of multiple sclerosis].
    Clanet M; Cambon-Thomsen A; Rascol A
    Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial predisposition to multiple sclerosis].
    Turpin JC; Dubois D; Delasnerie-Laupretre N
    Rev Neurol (Paris); 1986; 142(5):509-16. PubMed ID: 3787053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
    Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
    J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA and multiple sclerosis in south east Wales.
    Swingler RJ; Kirk PF; Darke C; Compston DA
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1153-5. PubMed ID: 3499485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.